AXGN
AxoGen, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +9.1% ·
share flow -24.8% ·
net new positions +8.3%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +13 | 31.59M | $1.46B | +13 | −1 |
| Q1 2026 | 88 | +4 | 26.93M | $890.85M | +13 | −9 |
| Q4 2025 | 84 | +1 | 23.54M | $770.31M | +1 | — |
| Q3 2025 | 15 | 0 | 12.88M | $229.79M | +1 | −2 |
| Q2 2025 | 13 | -3 | 10.16M | $110.24M | — | −3 |
| Q1 2025 | 13 | +1 | 4.00M | $74.03M | +1 | — |
| Q4 2024 | 12 | +1 | 2.94M | $48.52M | +2 | −1 |
| Q3 2024 | 10 | +4 | 2.95M | $41.31M | +4 | — |
| Q2 2024 | 6 | — | 2.53M | $18.31M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.01M | -0.3% | $16.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.01M | -0.3% | $16.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 965.61K | — | $15.91M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 488.31K | -23.0% | $8.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 131.18K | -86.3% | $2.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 97.29K | +37.0% | $1.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 91.59K | -17.0% | $1.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 91.59K | -17.0% | $1.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 77.00K | 0.0% | $1.27M | 0.0% | Held | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 34.82K | +10.2% | $574,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 22.00K | New | $362,560 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 16.46K | New | $271,326 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 16.46K | New | $271,326 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 16.46K | New | $271,326 | 0.0% | New | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 8.00K | -53.2% | $131,840 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 4.44K | -47.5% | $73,122 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 4.44K | -47.5% | $73,122 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $362,560 | 0.0% |
| AQR Capital Management | $271,326 | 0.0% |
| AQR Capital Management | $271,326 | 0.0% |
| AQR Capital Management | $271,326 | 0.0% |
Exited
| Two Sigma Investments | $370,030 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 219 holders, 49.68M shares, $1.61B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 13.35K sh · $646,592
Officer · 67.50K sh · $3.20M
Director · 14.15K sh · $640,967
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology